Hedge Fund - Tybourne Capital Management
Zentalis Pharmaceuticals Inc. (ZNTL)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $1,528,763 | 6.49% | 961,486 | $2.16 |
| 2 | 2024 - Q4 (2024-12-31) | $2,913,303 | 0.73% | 961,486 | $3.28 |
| 3 | 2024 - Q3 (2024-09-30) | $3,538,269 | 0.99% | 961,486 | $3.63 |
| 4 | 2024 - Q2 (2024-06-30) | $3,932,478 | 0.79% | 961,486 | $11.17 |
| 5 | 2024 - Q1 (2024-03-31) | $15,153,020 | 2.59% | 961,486 | $13.75 |
| 6 | 2023 - Q4 (2023-12-31) | $14,566,513 | 2.17% | 961,486 | $14.59 |
| 7 | 2023 - Q3 (2023-09-30) | $19,287,410 | 2.69% | 961,486 | $25.38 |
| 8 | 2023 - Q2 (2023-06-30) | $27,123,520 | 2.93% | 961,486 | $23.99 |
| 9 | 2023 - Q1 (2023-03-31) | $28,075,371 | 2.82% | 1,632,289 | $20.25 |
| 10 | 2022 - Q4 (2022-12-31) | $44,940,940 | 4.47% | 2,231,427 | $21.51 |
| 11 | 2022 - Q3 (2022-09-30) | $49,857,000 | 4.79% | 2,301,771 | $27.35 |
| 12 | 2022 - Q2 (2022-06-30) | $68,173,000 | 4.92% | 2,426,095 | $26.49 |
| 13 | 2022 - Q1 (2022-03-31) | $111,940,000 | 6.62% | 2,426,095 | $53.94 |
| 14 | 2021 - Q4 (2021-12-31) | $220,944,000 | 6.55% | 2,628,409 | $77.38 |
| 15 | 2021 - Q3 (2021-09-30) | $177,556,000 | 4.47% | 2,664,409 | $57.69 |
| 16 | 2021 - Q2 (2021-06-30) | $141,747,000 | 2.98% | 2,664,409 | $53.56 |
| 17 | 2021 - Q1 (2021-03-31) | $115,609,000 | 2.53% | 2,664,409 | $43.05 |
| 18 | 2020 - Q4 (2020-12-31) | $138,389,000 | 2.88% | 2,664,409 | $45.11 |
| 19 | 2020 - Q3 (2020-09-30) | $87,100,000 | 2.14% | 2,664,409 | $35.01 |
| 20 | 2020 - Q2 (2020-06-30) | $127,945,000 | 3.89% | 2,664,409 | $38.35 |
The displayed share prices are average quarterly stock market prices.